Novo Nordisk Raises 2012 Forecast as Profit Beats EstimatesSimeon Bennett and Albertina Torsoli
Novo Nordisk A/S, the world’s largest insulin maker, raised its full-year sales and profit forecasts after reporting second-quarter earnings that beat analysts’ estimates. The shares rose to a record.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.